Inspiring innovation and the future of digital therapeutics
Season 03: episode 10
In this week’s episode, GOLD speaks to Eugene Borukhovich, Co-Founder and COO, YourCoach.Health, about the evolving landscape of digital therapeutics (DTx) in pharma.
Following on from a recent GOLD feature on the topic, which Eugene contributed to, he discusses his journey into the pharmaceutical space, tips for pharma companies looking to get into DTx and his predictions for this tech evolution over coming years.
And in news you might have missed, the team showcases collaborative efforts against ebolavirus from the global health agencies CEPI, Gavi and WHO, and it’s good news for paediatric patients with compensated liver disease from Gilead Sciences.
A little more on GOLD’s guest…
Eugene Borukhovich, Co-founder and COO, YourCoach.Health, describes himself as a serial intra and entrepreneur with a focus on digital health. Prior to co-founding YourCoach.Health – a business looking to provide global access to digital health coaches with a holistic approach – he served as a Global Head of Digital Health at Bayer in Dusseldorf, Germany. He also currently sits on Almirall’s Digital Steering Board as an Executive Advisor. When not speaking to the next-best DTx company, Eugene enjoys running, writing, travelling and spending time with his family.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Click here to subscribe to the weekly newsletter for more insights from GOLD.